Company Filing History:
Years Active: 2001
Title: Géral Luc - Innovator in Genetic Therapy
Introduction
Géral Luc is a notable inventor based in Marcq en Baroeuil, France. He has made significant contributions to the field of genetic therapy, particularly through his work on apolipoprotein A-I variants. His innovative approach has the potential to impact therapeutic strategies in medicine.
Latest Patents
Géral Luc holds a patent for "Variants of apolipoprotein A-I." This invention relates to variants of the human apolipoprotein A-I that include a cysteine at position 151. The patent also encompasses the corresponding nucleic acids and vectors containing them. Furthermore, it details pharmaceutical compositions that utilize these elements, particularly in gene therapy applications. He has 1 patent to his name.
Career Highlights
Géral Luc is associated with Aventis Pharmaceuticals Products Inc., where he has been instrumental in advancing research in genetic therapies. His work has contributed to the understanding of apolipoproteins and their role in human health.
Collaborations
Géral has collaborated with notable colleagues such as Patrick Benoit and Eric Bruckert. Their combined expertise has fostered advancements in their respective fields.
Conclusion
Géral Luc's innovative work in the realm of genetic therapy showcases his commitment to advancing medical science. His contributions, particularly in the development of apolipoprotein A-I variants, highlight the importance of research in improving therapeutic options.